v3.25.2
Segment Information (Tables)
6 Months Ended
Jun. 30, 2025
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
There are no differences from the Company’s 2024 Form 10-K in the factors used to identify the reportable segments or measurement basis for segment loss. Significant segment expenses, as provided to the CODM, are presented below (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2025202420252024
Research and development payroll-related costs$5,089 $4,253 $10,321 $7,281 
General and administrative payroll-related costs2,003 1,750 4,156 3,299 
Clinical trial expenses6,023 3,043 12,032 5,238 
Chemistry, manufacturing, and controls costs3,124 5,842 7,470 10,235 
Medical affairs expenses977 657 1,532 944 
Research and development consulting expenses1,537 948 2,910 1,779 
General and administrative consulting expenses1,302 1,605 2,338 3,595 
Other segment items1
3,037 (611)5,303 (1,573)
Segment and consolidated net loss$23,092 $17,487 $46,062 $30,798 
1Other segment items include legal expenses, accounting expenses, IT and facilities expenses, insurance expenses, other operating expenses, interest income, investment income, stock-based compensation expense, depreciation expense, and other income, net.